Unigestion Holding’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-9,747
Closed -$920K 208
2021
Q3
$920K Buy
9,747
+896
+10% +$84.6K 0.04% 144
2021
Q2
$858K Sell
8,851
-786
-8% -$76.2K 0.03% 179
2021
Q1
$937K Buy
9,637
+1,892
+24% +$184K 0.03% 162
2020
Q4
$742K Sell
7,745
-1,304
-14% -$125K 0.03% 164
2020
Q3
$870K Buy
+9,049
New +$870K 0.03% 130